| Investor | Great Point Partners Llc |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Great Point Partners Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | 13G | 500,000 | ||||||
| 2026-05-15 | 13G | PMN / ProMIS Neurosciences, Inc. | 409,648 | 954,082 | ||||
| 2026-05-15 | 13G/A | ZURA / Zura Bio Limited | 3,815,930 | 4,215,930 | ||||
| 2026-05-15 | 13G/A | CNTX / Context Therapeutics Inc. | 4,683,711 | 2,238,496 | ||||
| 2026-04-24 | 13G | JATT / JATT II Acquisition Corp. | 500,000 | |||||
| 2026-04-07 | 13G | SCYX / SCYNEXIS, Inc. | 7,978,713 | |||||
| 2026-03-31 | 13G | SLGL / Sol-Gel Technologies Ltd. | 274,363 | |||||
| 2026-02-17 | 13G/A | PMN / ProMIS Neurosciences, Inc. | 5,972,369 | 409,648 | ||||
| 2026-02-17 | 13G/A | CNTX / Context Therapeutics Inc. | 4,683,711 | 4,683,711 | ||||
| 2026-02-17 | 13G/A | VTGN / Vistagen Therapeutics, Inc. | 2,055,834 | 2,055,834 | ||||
| 2026-02-17 | 13G/A | 6,783,269 | ||||||
| 2026-02-17 | 13G/A | ZURA / Zura Bio Limited | 3,815,930 | 3,815,930 | ||||
| 2026-02-17 | 13G/A | VOR / Vor Biopharma Inc. | 1,234,486 | 1,370,107 | ||||
| 2025-12-17 | 13G | VOR / Vor Biopharma Inc. | 1,234,486 | |||||
| 2025-11-14 | 13G/A | ZURA / Zura Bio Limited | 3,170,194 | 3,815,930 | ||||
| 2025-11-14 | 13G/A | VTGN / Vistagen Therapeutics, Inc. | 2,055,834 | 2,055,834 | ||||
| 2025-11-14 | 13G/A | UNCY / Unicycive Therapeutics, Inc. | 796,558 | 796,558 | ||||
| 2025-11-14 | 13G/A | PMN / ProMIS Neurosciences, Inc. | 3,334,520 | 5,972,369 | ||||
| 2025-11-14 | 13G/A | 8,636,151 | ||||||
| 2025-11-14 | 13G/A | CNTX / Context Therapeutics Inc. | 4,683,711 | 4,683,711 | ||||
| 2025-08-14 | 13G/A | UNCY / Unicycive Therapeutics, Inc. | 796,558 | |||||
| 2025-08-14 | 13G/A | OTLK / Outlook Therapeutics, Inc. | 2,220,000 | 2,220,000 | ||||
| 2025-08-14 | 13G/A | VTGN / Vistagen Therapeutics, Inc. | 2,055,834 | 2,055,834 | ||||
| 2025-08-14 | 13G/A | PMN / ProMIS Neurosciences, Inc. | 3,334,520 | 3,334,520 | ||||
| 2025-08-14 | 13G/A | CNTX / Context Therapeutics Inc. | 4,683,711 | 4,683,711 | ||||
| 2025-06-20 | 13G | 10,576,827 | ||||||
| 2025-05-15 | 13G/A | VTGN / Vistagen Therapeutics, Inc. | 2,055,834 | 2,055,834 | ||||
| 2025-05-15 | 13G/A | OTLK / Outlook Therapeutics, Inc. | 2,220,000 | 2,220,000 | ||||
| 2025-05-15 | 13G/A | OPTN / OptiNose, Inc. | 896,585 | 526,315 | ||||
| 2025-05-15 | 13G/A | CNTX / Context Therapeutics Inc. | 4,683,711 | 4,683,711 | ||||
| 2025-05-14 | 13G | ZURA / Zura Bio Limited | 3,170,194 | 3,170,194 | ||||
| 2025-02-14 | 13G/A | PMN / ProMIS Neurosciences, Inc. | 3,007,183 | 3,334,520 | ||||
| 2025-02-14 | 13G/A | UNCY / Unicycive Therapeutics, Inc. | 9,522,432 | 11,473,166 | ||||
| 2025-02-14 | 13G/A | VTGN / Vistagen Therapeutics, Inc. | 2,729,909 | 2,055,834 | ||||
| 2025-02-14 | 13G/A | OPTN / OptiNose, Inc. | 896,585 | |||||
| 2025-02-14 | 13G/A | OTLK / Outlook Therapeutics, Inc. | 2,481,973 | 2,220,000 | ||||
| 2025-02-14 | 13G/A | CNTX / Context Therapeutics Inc. | 6,934,982 | 4,683,711 | ||||
| 2025-02-14 | 13G/A | NGNE / Neurogene Inc. | 1,004,291 | 442,761 | ||||
| 2025-02-14 | 13G/A | ZURA / Zura Bio Limited | 3,263,672 | 3,170,194 | ||||
| 2024-11-14 | 13G/A | ZURA / Zura Bio Limited | 3,295,000 | 3,263,672 | ||||
| 2024-11-14 | 13G/A | UNCY / Unicycive Therapeutics, Inc. | 8,559,000 | 9,522,432 | ||||
| 2024-11-14 | 13G/A | VTGN / Vistagen Therapeutics, Inc. | 2,792,927 | 2,729,909 | ||||
| 2024-11-14 | 13G/A | PMN / ProMIS Neurosciences, Inc. | 3,005,698 | 3,007,183 | ||||
| 2024-11-14 | 13G/A | OPTN / OptiNose, Inc. | 11,484,120 | 15,306,939 | ||||
| 2024-11-14 | 13G/A | OTLK / Outlook Therapeutics, Inc. | 2,231,324 | 2,481,973 | ||||
| 2024-11-14 | 13G/A | NGNE / Neurogene Inc. | 994,229 | 1,004,291 | ||||
| 2024-11-14 | 13G/A | CNTX / Context Therapeutics Inc. | 7,419,355 | 6,934,982 | ||||
| 2024-11-14 | 13G/A | ELEV / Elevation Oncology, Inc. | 3,877,172 | 0 | ||||
| 2024-11-14 | 13G/A | URGN / UroGen Pharma Ltd. | 2,620,545 | 758,786 | ||||
| 2024-11-14 | 13G/A | ALPN / Alpine Immune Sciences, Inc. | 3,703,433 | 0 | ||||
| 2024-08-15 | 13G | ELEV / Elevation Oncology, Inc. | 3,877,172 | |||||
| 2024-08-05 | 13G | PMN / ProMIS Neurosciences, Inc. | 3,005,698 | |||||
| 2024-07-18 | 13G | UNCY / Unicycive Therapeutics, Inc. | 8,559,000 | |||||
| 2024-06-05 | 13G | CNTX / Context Therapeutics Inc. | 7,419,355 | |||||
| 2024-04-08 | 13G | OTLK / Outlook Therapeutics, Inc. | 2,231,324 | |||||
| 2024-02-14 | 13G/A | ZURA / Zura Bio Limited | 3,295,000 | 3,295,000 | ||||
| 2024-02-14 | 13G/A | NGNE / Neurogene Inc. | 969,229 | 994,229 | ||||
| 2024-02-14 | 13G/A | OPTN / OptiNose, Inc. | 11,314,719 | 11,484,120 | ||||
| 2024-02-14 | 13G/A | URGN / UroGen Pharma Ltd. | 2,620,545 | 2,620,545 | ||||
| 2024-02-14 | 13G/A | VTGN / Vistagen Therapeutics, Inc. | 2,792,927 | 2,792,927 | ||||
| 2024-02-14 | 13G/A | ALPN / Alpine Immune Sciences, Inc. | 3,637,718 | 3,703,433 | ||||
| 2024-02-14 | 13G/A | AVTX / Avalo Therapeutics, Inc. | 2,085 | |||||
| 2024-02-14 | 13G/A | DTIL / Precision BioSciences, Inc. | 8,099,799 | 0 | ||||
| 2024-02-14 | 13G/A | HRTX / Heron Therapeutics, Inc. | 6,360,161 | 0 | ||||
| 2023-12-27 | 13G | NGNE / Neurogene Inc. | 969,229 | |||||
| 2023-10-12 | 13G | VTGN / Vistagen Therapeutics, Inc. | 2,792,927 | |||||
| 2023-09-15 | 13G | URGN / UroGen Pharma Ltd. | 2,620,545 | |||||
| 2023-06-16 | 13G | ZURA / Zura Bio Limited | 3,295,000 | |||||
| 2023-04-13 | 13G | HRTX / Heron Therapeutics, Inc. | 6,360,161 | |||||
| 2023-02-27 | 13G | DTIL / Precision BioSciences, Inc. | 3,801,305 | 8,099,799 | ||||
| 2023-02-14 | 13G/A | KALV / KalVista Pharmaceuticals, Inc. | 1,280,000 | 1,055,801 | ||||
| 2023-02-14 | 13G/A | OPTN / OptiNose, Inc. | 11,314,719 | 11,314,719 | ||||
| 2023-02-14 | 13G/A | DTIL / Precision BioSciences, Inc. | 5,755,396 | 3,801,305 | ||||
| 2023-02-14 | 13G/A | ETNB / 89bio, Inc. | 2,100,000 | 700,000 | ||||
| 2023-02-14 | 13G/A | ALPN / Alpine Immune Sciences, Inc. | 3,448,521 | 3,637,718 | ||||
| 2023-02-13 | 13G | / Avalo Therapeutics Inc | 974,639 | |||||
| 2022-12-01 | 13G | OPTN / OptiNose, Inc. | 11,314,719 | |||||
| 2022-09-30 | 13G | ALPN / Alpine Immune Sciences, Inc. | 3,448,521 | |||||
| 2022-07-08 | 13G | ETNB / 89bio, Inc. | 2,100,000 | |||||
| 2022-07-01 | 13G | DTIL / Precision BioSciences, Inc. | 5,755,396 | |||||
| 2022-05-18 | 13G | KALV / KalVista Pharmaceuticals, Inc. | 1,280,000 | |||||
| 2022-02-14 | 13G/A | IFRX / InflaRx N.V. | 4,400,000 | 0 | ||||
| 2021-03-08 | 13G | IFRX / InflaRx N.V. | 4,400,000 | |||||
| 2021-02-16 | 13G/A | US2103731061 / Constellation Pharmaceuticals Inc | 2,301,457 | 1,024,800 | ||||
| 2021-02-16 | 13G/A | VYNE / VYNE Therapeutics Inc. | 1,652,013 | 0 | ||||
| 2021-02-16 | 13G/A | TGTX / TG Therapeutics, Inc. | 5,434,783 | 0 | ||||
| 2021-02-16 | 13G/A | GERN / Geron Corporation | 23,097,117 | 12,754,228 | ||||
| 2021-02-16 | 13G/A | NXTC / NextCure, Inc. | 1,376,532 | 0 | ||||
| 2021-02-16 | 13G/A | ZYME / Zymeworks Inc. | 2,223,789 | 799,722 | ||||
| 2021-02-16 | 13G/A | PRTA / Prothena Corporation plc | 2,100,941 | 977,647 | ||||
| 2021-02-16 | 13G/A | ABEO / Abeona Therapeutics Inc. | 8,488,882 | 0 | ||||
| 2021-02-16 | 13G/A | TPST / Tempest Therapeutics, Inc. | 1,729,759 | 270,000 | ||||
| 2020-07-07 | 13G | ABEO / Abeona Therapeutics Inc. | 8,480,470 | 8,488,882 | ||||
| 2020-06-05 | 13G | US2103731061 / Constellation Pharmaceuticals Inc | 2,301,457 | |||||
| 2020-06-01 | 13G | GERN / Geron Corporation | 23,097,117 | |||||
| 2020-04-22 | 13D/A | ABEO / Abeona Therapeutics Inc. | 8,459,960 | 8,480,470 | ||||
| 2020-02-21 | 13G | NXTC / NextCure, Inc. | 1,376,532 | |||||
| 2020-02-14 | 13G/A | CYTK / Cytokinetics, Incorporated | 3,173,288 | 160,073 | ||||
| 2020-02-14 | 13G/A | US33830X1046 / Five Prime Therapeutics Inc | 2,398,409 | 0 | ||||
| 2020-02-14 | 13G/A | STRM / Streamline Health Solutions, Inc. | 1,231,695 | 0 | ||||
| 2020-02-14 | 13G/A | SVRA / Savara Inc. | 1,819,195 | 0 | ||||
| 2020-02-14 | 13G/A | LRMR / Larimar Therapeutics, Inc. | 3,598,392 | 0 | ||||
| 2020-02-14 | 13G/A | ZGNX / Zogenix Inc | 2,250,000 | 670,000 | ||||
| 2020-02-14 | 13G/A | KURA / Kura Oncology, Inc. | 2,769,527 | 853,777 | ||||
| 2020-02-14 | 13G/A | TPST / Tempest Therapeutics, Inc. | 1,288,093 | 1,729,759 | ||||
| 2020-02-14 | 13G/A | PRTA / Prothena Corporation plc | 2,066,041 | 2,100,941 | ||||
| 2020-02-14 | 13G/A | VYNE / VYNE Therapeutics Inc. | 2,204,407 | 1,652,013 | ||||
| 2020-02-14 | 13G/A | FOMX / Foamix Pharmaceuticals Ltd. | 4,047,561 | 0 | ||||
| 2020-02-14 | 13G/A | BOLD / Boundless Bio, Inc. | 2,325,000 | 0 | ||||
| 2020-02-14 | 13G/A | BCRX / BioCryst Pharmaceuticals, Inc. | 7,622,256 | 0 | ||||
| 2020-02-14 | 13G/A | YMTX / Yumanity Therapeutics Inc | 3,045,423 | 0 | ||||
| 2020-02-14 | 13G/A | ZYME / Zymeworks Inc. | 2,082,799 | 2,223,789 | ||||
| 2020-01-02 | 13G | TGTX / TG Therapeutics, Inc. | 5,434,783 | |||||
| 2019-12-30 | 13D | ABEO / Abeona Therapeutics Inc. | 2,833,656 | 8,459,960 | ||||
| 2019-09-16 | 13G | ABEO / Abeona Therapeutics Inc. | 2,833,656 | |||||
| 2019-09-16 | 13G | BOLD / Boundless Bio, Inc. | 2,325,000 | |||||
| 2019-09-16 | 13G | ZGNX / Zogenix Inc | 1,121,331 | 2,250,000 | ||||
| 2019-08-09 | 13G | ZYME / Zymeworks Inc. | 2,082,799 | |||||
| 2019-08-05 | 13G | PRTA / Prothena Corporation plc | 2,066,041 | |||||
| 2019-05-14 | 13G | PBYI / Puma Biotechnology, Inc. | 1,970,000 | |||||
| 2019-05-14 | 13G/A | PBYI / Puma Biotechnology, Inc. | 1,096,626 | |||||
| 2019-02-14 | 13G/A | FOMX / Foamix Pharmaceuticals Ltd. | 4,030,268 | 4,047,561 | ||||
| 2019-02-14 | 13G/A | KURA / Kura Oncology, Inc. | 2,197,283 | 2,769,527 | ||||
| 2019-02-14 | 13G/A | VYNE / VYNE Therapeutics Inc. | 1,556,758 | 2,204,407 | ||||
| 2019-02-14 | 13G/A | TPST / Tempest Therapeutics, Inc. | 1,285,068 | 1,288,093 | ||||
| 2019-02-14 | 13G/A | SVRA / Savara Inc. | 2,243,084 | 1,819,195 | ||||
| 2019-02-14 | 13G/A | LRMR / Larimar Therapeutics, Inc. | 3,500,000 | 3,598,392 | ||||
| 2019-02-14 | 13G/A | YMTX / Yumanity Therapeutics Inc | 2,962,962 | 3,045,423 | ||||
| 2019-02-14 | 13G/A | US33830X1046 / Five Prime Therapeutics Inc | 1,821,548 | 2,398,409 | ||||
| 2019-02-14 | 13G/A | LUMO / Lumos Pharma, Inc. | 1,987,099 | 0 | ||||
| 2019-02-14 | 13G/A | CYTK / Cytokinetics, Incorporated | 3,173,288 | 3,173,288 | ||||
| 2019-02-14 | 13G/A | RIGL / Rigel Pharmaceuticals, Inc. | 7,888,581 | 0 | ||||
| 2019-02-14 | 13G/A | STRM / Streamline Health Solutions, Inc. | 18,325,483 | 1,231,695 | ||||
| 2019-02-14 | 13G/A | PTGX / Protagonist Therapeutics, Inc. | 1,473,609 | 955,618 | ||||
| 2019-01-11 | 13G | BCRX / BioCryst Pharmaceuticals, Inc. | 7,478,275 | 7,622,256 | ||||
| 2019-01-08 | 13D/A | CNXR / Connecture, Inc. | 42,396,565 | 0 | ||||
| 2018-12-17 | 13G | TPST / Tempest Therapeutics, Inc. | 1,285,068 | |||||
| 2018-11-15 | 13G | CYTK / Cytokinetics, Incorporated | 3,173,288 | |||||
| 2018-11-05 | 13G | YMTX / Yumanity Therapeutics Inc | 2,962,962 | |||||
| 2018-10-19 | 13G | US33830X1046 / Five Prime Therapeutics Inc | 1,821,548 | |||||
| 2018-10-10 | 13G/A | FOMX / Foamix Pharmaceuticals Ltd. | 4,781,708 | 4,030,268 | ||||
| 2018-08-13 | 13G | VYNE / VYNE Therapeutics Inc. | 1,556,758 | |||||
| 2018-08-06 | 13G | SVRA / Savara Inc. | 2,243,084 | |||||
| 2018-07-31 | 13D/A | BCRX / BioCryst Pharmaceuticals, Inc. | 7,478,275 | 7,478,275 | ||||
| 2018-07-09 | 13G | LRMR / Larimar Therapeutics, Inc. | 3,500,000 | |||||
| 2018-07-02 | 13G | PTGX / Protagonist Therapeutics, Inc. | 1,473,609 | |||||
| 2018-06-20 | 13D/A | BCRX / BioCryst Pharmaceuticals, Inc. | 7,478,275 | 7,478,275 | ||||
| 2018-02-16 | 13D | BCRX / BioCryst Pharmaceuticals, Inc. | 7,478,275 | 7,478,275 | ||||
| 2018-02-15 | 13D | BCRX / BioCryst Pharmaceuticals, Inc. | 7,478,275 | |||||
| 2018-02-14 | 13G/A | RCKT / Rocket Pharmaceuticals, Inc. | 0 | |||||
| 2018-02-14 | 13G/A | CPRX / Catalyst Pharmaceuticals, Inc. | 5,262,346 | 3,817,288 | ||||
| 2018-02-14 | 13G/A | VNDA / Vanda Pharmaceuticals Inc. | 2,216,216 | 797,531 | ||||
| 2018-02-14 | 13G/A | TRVN / Trevena, Inc. | 3,000,650 | 0 | ||||
| 2018-02-14 | 13G/A | ZGNX / Zogenix Inc | 24,805,773 | 1,121,331 | ||||
| 2018-02-14 | 13G/A | CNCE / Concert Pharmaceuticals Inc | 2,101,301 | 669,472 | ||||
| 2018-02-14 | 13G/A | 451731103 / Ignyta, Inc. | 4,000,000 | 0 | ||||
| 2018-02-14 | 13G/A | KURA / Kura Oncology, Inc. | 1,638,461 | 2,197,283 | ||||
| 2018-02-14 | 13G/A | RCKT / Rocket Pharmaceuticals, Inc. | 1,500,000 | 0 | ||||
| 2018-02-14 | 13G/A | APYX / Apyx Medical Corporation | 30,842,683 | 0 | ||||
| 2018-02-14 | 13G/A | FOMX / Foamix Pharmaceuticals Ltd. | 4,781,708 | 4,781,708 | ||||
| 2018-02-14 | 13G/A | OCRX / Ocera Therapeutics, Inc. | 20,693,361 | 0 | ||||
| 2018-02-14 | 13D/A | CNXR / Connecture, Inc. | 42,396,565 | 4,239,656 | ||||
| 2018-02-14 | 13G/A | LUMO / Lumos Pharma, Inc. | 1,500,000 | 1,987,099 | ||||
| 2018-02-14 | 13G/A | ARNA / Arena Pharmaceuticals Inc | 30,000,000 | 1,177,119 | ||||
| 2018-02-14 | 13G/A | PTCT / PTC Therapeutics, Inc. | 21,600,001 | 1,085,800 | ||||
| 2018-02-14 | 13G/A | 867328601 / Sunesis Pharmaceuticals, Inc. | 19,878,713 | 0 | ||||
| 2018-02-14 | 13G/A | RIGL / Rigel Pharmaceuticals, Inc. | 9,105,691 | 7,888,581 | ||||
| 2018-02-14 | 13G/A | ARDM / Aradigm Corp. | 791,870 | 0 | ||||
| 2018-02-14 | 13G/A | STRM / Streamline Health Solutions, Inc. | 21,349,403 | 1,832,548 | ||||
| 2018-01-09 | 13D | CNXR / Connecture, Inc. | 42,396,565 | 4,239,656 | ||||
| 2017-12-08 | 13G | CPRX / Catalyst Pharmaceuticals, Inc. | 5,262,346 | |||||
| 2017-10-10 | 13G/A | ADMS / Adamas Pharmaceuticals Inc | 2,601,351 | 256,340 | ||||
| 2017-08-21 | 13G | KURA / Kura Oncology, Inc. | 1,638,461 | |||||
| 2017-06-16 | 13G | PTCT / PTC Therapeutics, Inc. | 2,160,000 | |||||
| 2017-06-05 | 13G | LUMO / Lumos Pharma, Inc. | 1,500,000 | |||||
| 2017-05-10 | 13G/A | FOMX / Foamix Pharmaceuticals Ltd. | 3,000,000 | 4,781,708 | ||||
| 2017-04-28 | 13G | ARNA / Arena Pharmaceuticals Inc | 30,000,000 | |||||
| 2017-03-16 | 13G | CNCE / Concert Pharmaceuticals Inc | 2,101,301 | |||||
| 2017-02-17 | 13G | VNDA / Vanda Pharmaceuticals Inc. | 2,010,000 | 2,216,216 | ||||
| 2017-02-14 | 13G/A | ARCT / Arcturus Therapeutics Holdings Inc. | 2,012,622 | 0 | ||||
| 2017-02-14 | 13G/A | TRVN / Trevena, Inc. | 2,931,900 | 3,000,650 | ||||
| 2017-02-14 | 13G/A | FOMX / Foamix Pharmaceuticals Ltd. | 2,769,425 | 3,000,000 | ||||
| 2017-02-14 | 13G/A | ALIM / Alimera Sciences, Inc. | 3,245,000 | 2,293,675 | ||||
| 2017-02-14 | 13G/A | VNDA / Vanda Pharmaceuticals Inc. | 2,334,119 | 2,010,000 | ||||
| 2017-02-14 | 13G/A | 451731103 / Ignyta, Inc. | 2,169,916 | 4,000,000 | ||||
| 2017-02-14 | 13G/A | VCEL / Vericel Corporation | 2,086,028 | 0 | ||||
| 2017-02-14 | 13G/A | US88165N2045 / Tetraphase Pharmaceuticals, Inc. | 1,940,000 | 0 | ||||
| 2017-02-14 | 13G/A | ARDM / Aradigm Corp. | 1,002,962 | 791,870 | ||||
| 2017-02-14 | 13G/A | AUPH / Aurinia Pharmaceuticals Inc. | 30,756,603 | 0 | ||||
| 2017-02-14 | 13G/A | APYX / Apyx Medical Corporation | 3,046,272 | 3,084,268 | ||||
| 2017-02-14 | 13G/A | ZGNX / Zogenix Inc | 15,185,213 | 2,480,577 | ||||
| 2017-02-14 | 13G/A | ADMS / Adamas Pharmaceuticals Inc | 1,437,335 | 2,601,351 | ||||
| 2017-02-14 | 13G/A | RCKT / Rocket Pharmaceuticals, Inc. | 1,366,500 | 1,500,000 | ||||
| 2017-02-14 | 13G/A | STRM / Streamline Health Solutions, Inc. | 20,667,643 | 2,134,940 | ||||
| 2017-02-14 | 13G/A | 867328601 / Sunesis Pharmaceuticals, Inc. | 85,123,853 | 1,987,871 | ||||
| 2017-02-14 | 13G/A | OCRX / Ocera Therapeutics, Inc. | 20,597,081 | 2,069,336 | ||||
| 2017-02-10 | 13G | RIGL / Rigel Pharmaceuticals, Inc. | 9,105,691 | |||||
| 2017-02-06 | 13D | CNXR / Connecture, Inc. | 4,210,960 | 4,239,656 | ||||
| 2017-01-03 | 13G | RCKT / Rocket Pharmaceuticals, Inc. | 1,366,500 | |||||
| 2016-12-12 | 13G | TRVN / Trevena, Inc. | 2,931,900 | |||||
| 2016-11-23 | 13D/A | APYX / Apyx Medical Corporation | 27,192,661 | 3,046,272 | ||||
| 2016-10-11 | 13G | FOMX / Foamix Pharmaceuticals Ltd. | 2,769,425 | |||||
| 2016-08-22 | 13G | ALIM / Alimera Sciences, Inc. | 0 | 3,245,000 | ||||
| 2016-05-23 | 13G | 451731103 / Ignyta, Inc. | 2,050,000 | 2,169,916 | ||||
| 2016-05-09 | 13G | 451731103 / Ignyta, Inc. | 2,050,000 | |||||
| 2016-02-26 | 13D | APYX / Apyx Medical Corporation | 27,192,663 | 2,719,266 | ||||
| 2016-02-16 | 13G/A | ARCT / Arcturus Therapeutics Holdings Inc. | 1,124,186 | 2,012,622 | ||||
| 2016-02-16 | 13G | AUPH / Aurinia Pharmaceuticals Inc. | 3,075,660 | |||||
| 2016-02-16 | 13G/A | APYX / Apyx Medical Corporation | 2,719,266 | |||||
| 2016-02-16 | 13G/A | VCEL / Vericel Corporation | 2,086,028 | |||||
| 2016-02-16 | 13G/A | SYN / Synthetic Biologics Inc | 3,589,400 | |||||
| 2016-02-16 | 13G/A | PTN / Palatin Technologies, Inc. | 2,337,000 | |||||
| 2016-02-16 | 13G/A | DSCO / Doubleline ETF Trust - DoubleLine Securitized Credit ETF | 64,962,513 | 280,952 | ||||
| 2016-02-16 | 13G/A | ACHV / Achieve Life Sciences, Inc. | 0 | |||||
| 2016-02-16 | 13G/A | CBMX / CombiMatrix Corp. | 0 | |||||
| 2016-02-16 | 13G/A | ZGNX / Zogenix Inc | 14,663,573 | 1,518,521 | ||||
| 2016-02-16 | 13G/A | SGYPQ / SYNERGY PHARMACEUTICALS INC DEL | 1,546,888 | |||||
| 2016-02-16 | 13G/A | ADMS / Adamas Pharmaceuticals Inc | 1,080,000 | 1,437,335 | ||||
| 2016-02-16 | 13G/A | ALBO / Albireo Pharma Inc | 54,308,554 | 0 | ||||
| 2016-02-16 | 13G/A | OCRX / Ocera Therapeutics, Inc. | 2,059,708 | |||||
| 2016-02-16 | 13G/A | ALIM / Alimera Sciences, Inc. | 0 | |||||
| 2016-02-16 | 13G/A | CNXR / Connecture, Inc. | 4,127,232 | 4,210,960 | ||||
| 2016-02-16 | 13G/A | VIRX / Viracta Therapeutics, Inc. | 85,123,503 | 8,512,385 | ||||
| 2016-02-16 | 13G/A | SSKN / STRATA Skin Sciences, Inc. | 0 | |||||
| 2016-02-16 | 13G/A | ARDM / Aradigm Corp. | 1,002,962 | |||||
| 2016-02-16 | 13G/A | STRM / Streamline Health Solutions, Inc. | 2,066,764 | |||||
| 2016-01-15 | 13G | VNDA / Vanda Pharmaceuticals Inc. | 2,334,119 | |||||
| 2015-12-28 | 13G | VIRX / Viracta Therapeutics, Inc. | 8,512,350 | |||||
| 2015-12-24 | 13G | US88165N2045 / Tetraphase Pharmaceuticals, Inc. | 1,824,300 | 1,940,000 | ||||
| 2015-11-06 | 13G | US88165N2045 / Tetraphase Pharmaceuticals, Inc. | 1,824,300 | |||||
| 2015-10-05 | 13G | ZGNX / Zogenix Inc | 1,466,357 | |||||
| 2015-08-24 | 13G | ADMS / Adamas Pharmaceuticals Inc | 1,080,000 | |||||
| 2015-07-28 | 13G | WINT / Windtree Therapeutics, Inc. | 6,496,251 | |||||
| 2015-04-28 | 13G | ALBO / Albireo Pharma Inc | 5,430,855 | |||||
| 2015-04-16 | 13G | ARCT / Arcturus Therapeutics Holdings Inc. | 1,124,186 | |||||
| 2015-02-17 | 13G/A | SYN / Synthetic Biologics Inc | 7,588,341 | |||||
| 2015-02-17 | 13G/A | ARDM / Aradigm Corp. | 1,002,962 | |||||
| 2015-02-17 | 13G/A | SPHS / Sophiris Bio Inc | 0 | |||||
| 2015-02-17 | 13G/A | MELA / MELA Sciences, Inc | 670,058 | |||||
| 2015-02-17 | 13G/A | ANTH / Anthera Pharmaceuticals, Inc. | 250,000 | |||||
| 2015-02-17 | 13G/A | TENX / Tenax Therapeutics, Inc. | 0 | |||||
| 2015-02-17 | 13G/A | WGBS / WaferGen Bio-Systems, Inc. | 132,456 | |||||
| 2015-02-17 | 13G | CNXR / Connecture, Inc. | 5,502,965 | |||||
| 2015-02-17 | 13G/A | ACHV / Achieve Life Sciences, Inc. | 1,726,064 | |||||
| 2015-02-17 | 13G/A | STRM / Streamline Health Solutions, Inc. | 2,031,889 | |||||
| 2015-02-17 | 13G/A | OCRX / Ocera Therapeutics, Inc. | 1,973,136 | |||||
| 2015-02-17 | 13G/A | NUWE / Nuwellis, Inc. | 0 | |||||
| 2015-02-17 | 13G/A | APYX / Apyx Medical Corporation | 1,991,588 | |||||
| 2015-02-17 | 13G/A | REPH / Societal CDMO Inc | 0 | |||||
| 2015-02-17 | 13G/A | CBMX / CombiMatrix Corp. | 970,874 | |||||
| 2015-02-17 | 13G/A | ALIM / Alimera Sciences, Inc. | 2,619,853 | |||||
| 2015-02-17 | 13G/A | SAVA / Cassava Sciences, Inc. | 0 | |||||
| 2015-02-17 | 13G/A | AVEO / AVEO Pharmaceuticals Inc | 0 | |||||
| 2015-01-20 | 13G | ARCT / Arcturus Therapeutics Holdings Inc. | 1,132,000 | |||||
| 2014-11-10 | 13G | SGYPQ / SYNERGY PHARMACEUTICALS INC DEL | 6,430,868 | |||||
| 2014-10-24 | 13G | MELA / MELA Sciences, Inc | 601,299 | |||||
| 2014-10-20 | 13G | SYN / Synthetic Biologics Inc | 7,321,380 | |||||
| 2014-09-25 | 13G | ALIM / Alimera Sciences, Inc. | 2,468,662 | |||||
| 2014-09-22 | 13G | VCEL / Vericel Corporation | 2,170,000 | |||||
| 2014-07-21 | 13G | OCRX / Ocera Therapeutics, Inc. | 1,964,874 | |||||
| 2014-07-07 | 13G | 02318X100 / Ambit Biosciences Corp | 1,053,895 | |||||
| 2014-07-07 | 13G | ACHV / Achieve Life Sciences, Inc. | 2,111,590 | |||||
| 2014-03-28 | 13G | TENX / Tenax Therapeutics, Inc. | 2,000,000 | |||||
| 2014-03-18 | 13G | REPH / Societal CDMO Inc | 580,000 | |||||
| 2014-02-18 | 13G | ANTH / Anthera Pharmaceuticals, Inc. | 1,000,000 | |||||
| 2014-02-14 | 13G/A | SAVA / Cassava Sciences, Inc. | 2,797,689 | |||||
| 2014-02-14 | 13G/A | SVRA / Savara Inc. | 4,194,934 | |||||
| 2014-02-14 | 13G/A | STRM / Streamline Health Solutions, Inc. | 1,929,273 | |||||
| 2014-02-14 | 13G/A | 02318X100 / Ambit Biosciences Corp | 732,600 | |||||
| 2014-02-14 | 13G/A | ALBO / Albireo Pharma Inc | 1,048,024 | |||||
| 2014-02-14 | 13G/A | AVEO / AVEO Pharmaceuticals Inc | 3,000,000 | |||||
| 2014-02-14 | 13G/A | VNDA / Vanda Pharmaceuticals Inc. | 0 | |||||
| 2014-02-14 | 13G/A | WGBS / WaferGen Bio-Systems, Inc. | 994,741 | |||||
| 2014-02-14 | 13G | CBMX / CombiMatrix Corp. | 1,095,541 | |||||
| 2014-02-14 | 13G/A | FURX / Furiex Pharmaceuticals, Inc. | 319,536 | |||||
| 2014-02-14 | 13G/A | NUWE / Nuwellis, Inc. | 915,917 | |||||
| 2014-02-14 | 13G/A | SPHS / Sophiris Bio Inc | 1,379,660 | |||||
| 2014-02-14 | 13G/A | PTN / Palatin Technologies, Inc. | 2,337,000 | |||||
| 2014-02-14 | 13G/A | ACHV / Achieve Life Sciences, Inc. | 217,301 | |||||
| 2014-02-06 | 13G | ARDM / Aradigm Corp. | 40,322,580 | |||||
| 2013-12-30 | 13G | AVEO / AVEO Pharmaceuticals Inc | 2,950,100 | |||||
| 2013-12-23 | 13G | APYX / Apyx Medical Corporation | 1,947,747 | |||||
| 2013-08-26 | 13G | SPHS / Sophiris Bio Inc | 1,280,000 | |||||
| 2013-07-08 | 13G | SAVA / Cassava Sciences, Inc. | 2,386,700 | |||||
| 2013-06-24 | 13G | SVRA / Savara Inc. | 8,700,000 | |||||
| 2013-05-28 | 13G | 02318X100 / Ambit Biosciences Corp | 1,000,000 | |||||
| 2013-05-28 | 13G | STML / Stemline Therapeutics, Inc. | 620,627 | |||||
| 2013-04-22 | 13G | NUWE / Nuwellis, Inc. | 950,000 | |||||
| 2013-02-14 | 13G/A | OREX / Orexigen Therapeutics, Inc. | 0 | |||||
| 2013-02-14 | 13G/A | STRM / Streamline Health Solutions, Inc. | 1,402,102 | |||||
| 2013-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 482,001 | |||||
| 2013-02-14 | 13G/A | TNGNQ / Tengion, Inc. | 0 | |||||
| 2013-02-14 | 13G/A | ALBO / Albireo Pharma Inc | 1,374,228 | |||||
| 2013-02-14 | 13G/A | VNDA / Vanda Pharmaceuticals Inc. | 2,300,021 | |||||
| 2013-02-14 | 13G/A | WGBS / WaferGen Bio-Systems, Inc. | 4,622,922 | |||||
| 2013-02-14 | 13G/A | ZGNX / Zogenix Inc | 3,697,900 | |||||
| 2013-02-14 | 13G/A | ASMB / Assembly Biosciences, Inc. | 0 | |||||
| 2013-02-14 | 13G/A | FURX / Furiex Pharmaceuticals, Inc. | 631,737 | |||||
| 2013-02-14 | 13G/A | PTN / Palatin Technologies, Inc. | 2,637,207 | |||||
| 2013-02-14 | 13G/A | WINT / Windtree Therapeutics, Inc. | 871,454 | |||||
| 2013-02-14 | 13G/A | ACHV / Achieve Life Sciences, Inc. | 1,039,793 | |||||
| 2012-12-10 | 13G | VNDA / Vanda Pharmaceuticals Inc. | 1,930,000 | |||||
| 2012-12-10 | 13G | FURX / Furiex Pharmaceuticals, Inc. | 525,000 | |||||
| 2012-08-27 | 13G | STRM / Streamline Health Solutions, Inc. | 1,385,611 | |||||
| 2012-08-03 | 13G | ZGNX / Zogenix Inc | 5,750,000 | |||||
| 2012-02-14 | 13G/A | IMNP / Immune Pharmaceuticals Inc. | 3,181,818 | |||||
| 2012-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 2,618,418 | |||||
| 2012-02-14 | 13G/A | SLTM / Solta Medical Inc | 1,485,149 | |||||
| 2012-02-14 | 13G/A | DVAX / Dynavax Technologies Corporation | 4,750,000 | |||||
| 2012-02-14 | 13G/A | ANIP / ANI Pharmaceuticals, Inc. | 882,353 | |||||
| 2012-02-14 | 13G/A | BDSI / Biodelivery Sciences International | 0 | |||||
| 2012-02-14 | 13G | OREX / Orexigen Therapeutics, Inc. | 5,895,301 | |||||
| 2012-02-14 | 13G/A | TNGNQ / Tengion, Inc. | 1,901,603 | |||||
| 2012-02-14 | 13G | ASMB / Assembly Biosciences, Inc. | 750,000 | |||||
| 2012-02-14 | 13G/A | WINT / Windtree Therapeutics, Inc. | 2,200,000 | |||||
| 2012-02-14 | 13G/A | ACHV / Achieve Life Sciences, Inc. | 894,114 |